SG11201900753VA - A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium - Google Patents
A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture mediumInfo
- Publication number
- SG11201900753VA SG11201900753VA SG11201900753VA SG11201900753VA SG11201900753VA SG 11201900753V A SG11201900753V A SG 11201900753VA SG 11201900753V A SG11201900753V A SG 11201900753VA SG 11201900753V A SG11201900753V A SG 11201900753VA SG 11201900753V A SG11201900753V A SG 11201900753VA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- umbilical cord
- mesenchymal stem
- amniotic membrane
- culture medium
- Prior art date
Links
- 210000003954 umbilical cord Anatomy 0.000 title abstract 5
- 210000001691 amnion Anatomy 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 210000002901 mesenchymal stem cell Anatomy 0.000 title abstract 3
- 239000006143 cell culture medium Substances 0.000 title abstract 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 abstract 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 abstract 2
- 239000012091 fetal bovine serum Substances 0.000 abstract 2
- 239000002609 medium Substances 0.000 abstract 2
- 102100022464 5'-nucleotidase Human genes 0.000 abstract 1
- 101100163869 Arabidopsis thaliana AS1 gene Proteins 0.000 abstract 1
- 102100037241 Endoglin Human genes 0.000 abstract 1
- 102000006354 HLA-DR Antigens Human genes 0.000 abstract 1
- 108010058597 HLA-DR Antigens Proteins 0.000 abstract 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 abstract 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 abstract 1
- 101000881679 Homo sapiens Endoglin Proteins 0.000 abstract 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 abstract 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 abstract 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 abstract 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 abstract 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides, bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
- C12N2506/025—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells from extra-embryonic cells, e.g. trophoblast, placenta
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662404582P | 2016-10-05 | 2016-10-05 | |
PCT/SG2017/050500 WO2018067071A1 (en) | 2016-10-05 | 2017-10-05 | A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201900753VA true SG11201900753VA (en) | 2019-02-27 |
Family
ID=61832065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201900753VA SG11201900753VA (en) | 2016-10-05 | 2017-10-05 | A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium |
Country Status (18)
Country | Link |
---|---|
US (3) | US10988736B2 (zh) |
EP (1) | EP3523421A4 (zh) |
JP (2) | JP7262775B2 (zh) |
KR (1) | KR102491558B1 (zh) |
CN (1) | CN109804063A (zh) |
AU (2) | AU2017339344B2 (zh) |
BR (1) | BR112019005652A2 (zh) |
CA (1) | CA3031978A1 (zh) |
CL (1) | CL2019000540A1 (zh) |
CO (1) | CO2019002569A2 (zh) |
IL (2) | IL264197B2 (zh) |
MX (1) | MX2019003936A (zh) |
PH (1) | PH12019500187A1 (zh) |
SA (1) | SA519401455B1 (zh) |
SG (1) | SG11201900753VA (zh) |
TW (1) | TWI773693B (zh) |
WO (1) | WO2018067071A1 (zh) |
ZA (1) | ZA201900207B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2713062T3 (es) | 2005-09-27 | 2019-05-17 | Tissuetech Inc | Preparaciones de membrana amniótica y composiciones purificadas y métodos de uso |
CN114652816A (zh) | 2012-07-11 | 2022-06-24 | 组织技术公司 | 含有hc-ha/ptx3复合物的组合物及其使用方法 |
TW201642914A (zh) | 2015-02-23 | 2016-12-16 | 組織科技股份有限公司 | 用於治療眼部疾病及失調的裝置及方法 |
WO2016187555A1 (en) | 2015-05-20 | 2016-11-24 | Tissuetech, Inc. | Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells |
TW201733600A (zh) | 2016-01-29 | 2017-10-01 | 帝聖工業公司 | 胎兒扶持組織物及使用方法 |
AU2017339344B2 (en) * | 2016-10-05 | 2023-10-19 | Cellresearch Corporation Pte. Ltd. | A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium |
KR102015502B1 (ko) * | 2018-03-29 | 2019-08-28 | 아키소스템바이오스트래티지스(주) | 인간 제대로부터 줄기세포를 분리하는 방법 |
JP7446619B2 (ja) | 2018-04-09 | 2024-03-11 | セルリサーチ コーポレイション プライベート リミテッド | 輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法 |
WO2019199230A1 (en) * | 2018-04-09 | 2019-10-17 | Cellresearch Corporation Pte. Ltd. | A method of transporting mesenchymal stem cells by means of a cell culture medium and a method of administering stem cells to wounds |
TW202012618A (zh) * | 2018-04-12 | 2020-04-01 | 新加坡商細胞研究私人有限公司 | 一種誘導或改善間質幹細胞傷口癒合特性的方法 |
WO2020051141A1 (en) * | 2018-09-04 | 2020-03-12 | Academia Sinica | A medium composition and method for culturing mesenchymal stem cells |
CA3152751A1 (en) * | 2019-10-08 | 2021-04-15 | Toan Thang Phan | A mesenchymal stem cell storing or transport formulation and methods of making and using the same |
BR112022005673A2 (pt) * | 2019-10-08 | 2022-06-21 | Cellresearch Corp Pte Ltd | Método para avaliar a potência de cicatrização de feridas de uma população de células tronco mesenquimais e métodos relacionados para selecionar células tronco mesenquimais e identificar tecido como material de partida para produzir uma população de células tronco mesenquimais |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2527293T3 (es) | 2004-08-16 | 2015-01-22 | Cellresearch Corporation Pte Ltd | Aislamiento de células madre/progenitoras de membrana amniótica del cordón umbilical |
WO2007046775A1 (en) | 2005-10-21 | 2007-04-26 | Cellresearch Corporation Pte Ltd | Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom |
CN101525594B (zh) * | 2009-04-17 | 2011-04-20 | 中国医学科学院血液学研究所 | 一种培养间充质干细胞的低血清浓度完全培养基和利用该培养基培养间充质干细胞的方法 |
CN103266081B (zh) * | 2012-01-21 | 2015-05-13 | 中国人民解放军军事医学科学院附属医院 | 从脐带中分离培养间充质干细胞的高效方法 |
US8940294B2 (en) * | 2012-03-02 | 2015-01-27 | Tissuetech, Inc. | Methods of isolating and culturing stem cells |
CN103013917A (zh) * | 2012-11-30 | 2013-04-03 | 陆华 | 人羊膜间充质干细胞分化为神经元样细胞的诱导方法 |
JP6114840B2 (ja) * | 2013-03-01 | 2017-04-12 | アプセト ゲーエムベーハー アンド ツェーオー.カーゲー | ヒトcd34陰性前駆細胞による免疫に媒介される細胞傷害性反応からの血管内皮の保護 |
JP6745449B2 (ja) * | 2013-12-27 | 2020-08-26 | ゼノアックリソース株式会社 | 臍帯組織の凍結保存方法 |
CN105420184A (zh) * | 2015-12-11 | 2016-03-23 | 郭镭 | 一种从脐带外层羊膜组织中分离培养脐带间充质干细胞的方法 |
CN105420179A (zh) * | 2015-12-17 | 2016-03-23 | 斯坦姆(天津)生物技术研究有限公司 | 一种从脐带和胎盘羊膜组织同时提取上皮细胞和间充质干细胞的方法 |
AU2017339344B2 (en) * | 2016-10-05 | 2023-10-19 | Cellresearch Corporation Pte. Ltd. | A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium |
TW202002999A (zh) * | 2018-04-06 | 2020-01-16 | 新加坡商細胞研究私人有限公司 | 臍帶羊膜的基本上純的間質幹細胞群用於產生攜帶轉殖基因的哺乳動物幹細胞的用途 |
CA3152751A1 (en) * | 2019-10-08 | 2021-04-15 | Toan Thang Phan | A mesenchymal stem cell storing or transport formulation and methods of making and using the same |
-
2017
- 2017-10-05 AU AU2017339344A patent/AU2017339344B2/en active Active
- 2017-10-05 SG SG11201900753VA patent/SG11201900753VA/en unknown
- 2017-10-05 JP JP2019515832A patent/JP7262775B2/ja active Active
- 2017-10-05 CA CA3031978A patent/CA3031978A1/en active Pending
- 2017-10-05 BR BR112019005652A patent/BR112019005652A2/pt unknown
- 2017-10-05 IL IL264197A patent/IL264197B2/en unknown
- 2017-10-05 MX MX2019003936A patent/MX2019003936A/es unknown
- 2017-10-05 WO PCT/SG2017/050500 patent/WO2018067071A1/en unknown
- 2017-10-05 IL IL307825A patent/IL307825A/en unknown
- 2017-10-05 EP EP17858825.7A patent/EP3523421A4/en active Pending
- 2017-10-05 CN CN201780061207.1A patent/CN109804063A/zh active Pending
- 2017-10-05 US US15/725,913 patent/US10988736B2/en active Active
- 2017-10-05 TW TW106134409A patent/TWI773693B/zh active
- 2017-10-05 KR KR1020197004328A patent/KR102491558B1/ko active IP Right Grant
-
2019
- 2019-01-11 ZA ZA2019/00207A patent/ZA201900207B/en unknown
- 2019-01-25 PH PH12019500187A patent/PH12019500187A1/en unknown
- 2019-02-28 CL CL2019000540A patent/CL2019000540A1/es unknown
- 2019-03-19 CO CONC2019/0002569A patent/CO2019002569A2/es unknown
- 2019-03-31 SA SA519401455A patent/SA519401455B1/ar unknown
-
2021
- 2021-03-02 US US17/190,228 patent/US11821006B2/en active Active
-
2022
- 2022-12-27 JP JP2022209799A patent/JP2023036882A/ja active Pending
-
2023
- 2023-11-06 US US18/387,192 patent/US20240141298A1/en active Pending
-
2024
- 2024-01-18 AU AU2024200348A patent/AU2024200348A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201900753VA (en) | A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium | |
SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
SG11201909432SA (en) | Compounds for increasing genome editing efficiency | |
SG11201909710XA (en) | Indole ahr inhibitors and uses thereof | |
SG11201803983UA (en) | Transformable tagging compositions, methods, and processes incorporating same | |
SG11201808990QA (en) | Compositions for topical application of compounds | |
SG11201807573VA (en) | Methods for providing single-stranded rna | |
SG11201810179RA (en) | Novel crispr enzymes and systems | |
SG11201908391XA (en) | Methods for modulating an immune response | |
SG11201909949XA (en) | Targeted immunotolerance | |
SG11201809040YA (en) | Hybrid aerosol-generating element and method for manufacturing a hybrid aerosol-generating element | |
SG11201806758VA (en) | Vcn enhancer compositions and methods of using the same | |
SG11201805645QA (en) | Lsd1 inhibitors | |
SG11201805835WA (en) | Modified oncolytic virus | |
SG11201810048VA (en) | Tri-segmented pichinde viruses as vaccine vectors | |
SG11201811643TA (en) | Compounds and methods for modulating rna function | |
SG11201901996UA (en) | Formulations of ( r)-2-amino-3-phenylpropyl carbamate | |
SG11201900058YA (en) | Method of generating mesenchymal stem cells and uses thereof | |
SG11201804710TA (en) | Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof | |
SG11201807134RA (en) | Transposon system and methods of use | |
SG11201809594WA (en) | Nicotine particles and compositions | |
SG11201805052YA (en) | Therapeutic methods using erythrocytes | |
SG11201806094SA (en) | Bead beating tube and method for extracting deoxyribonucleic acid and/or ribonucleic acid from microorganisms | |
SG11201804916PA (en) | Three-dimensional polymer networks with channels situated therein | |
SG11201907420VA (en) | Inhibition of smarca2 for treatment of cancer |